Fitch assigns ‘BB’ rating to Glenmark’s proposed US dollar-denominated senior unsecured notes

By: |
New Delhi | Published: January 14, 2020 12:30 PM

"Fitch Ratings has assigned a rating of 'BB' to Glenmark Pharmaceuticals Ltd's (BB/Stable) proposed US dollar-denominated senior unsecured notes," it said in a statement.

Fitch, Fitch Ratings, Glenmark, BB rating, Glenmark Pharmaceuticals bb rating, Glenmark Pharmaceuticals fitch ratingAccording to Fitch, ‘BB’ ratings indicate an elevated vulnerability to default risk, particularly in the event of adverse changes in business or economic conditions over time. (Reuters)

Fitch Ratings on Tuesday said it has assigned Glenmark Pharmaceuticals Ltd’s proposed US dollar-denominated senior unsecured notes ‘BB’ rating with a stable outlook. “Fitch Ratings has assigned a rating of ‘BB’ to Glenmark Pharmaceuticals Ltd’s (BB/Stable) proposed US dollar-denominated senior unsecured notes,” it said in a statement.

According to Fitch, ‘BB’ ratings indicate an elevated vulnerability to default risk, particularly in the event of adverse changes in business or economic conditions over time. However, business or financial flexibility exists that supports the servicing of financial commitments.

The proposed notes, it said, are rated at the same level as Glenmark’s issuer default rating because they will represent its direct, unconditional, unsecured and unsubordinated obligations. Glenmark’s credit profile, the rating agency said, remains broadly unaffected by the proposed issuance, as the company intends to use the proceeds to repay debt.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1Retail collections improved, loans under moratorium reduced: DHFL
2Nabard launches Rs 5,000-crore scheme for computerisation of PACS by FY23
3HSBC gets nod to set up IBU at GIFT City